These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 381727)

  • 1. [New biological activity of complement and solubilization of immune complexes].
    Takahashi M
    Nihon Rinsho; 1979 May; 37(5):963-8. PubMed ID: 381727
    [No Abstract]   [Full Text] [Related]  

  • 2. Solubilization of antigen-antibody complexes: a new function of complement as a regulator of immune reactions.
    Takahashi M; Takahashi S; Hirose S
    Prog Allergy; 1980; 27():134-66. PubMed ID: 6986046
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody activity and complement-mediated solubilization of precipitates during the immune response.
    Stassen FL; Beek CJ
    Immunology; 1982 Jun; 46(2):289-95. PubMed ID: 7084992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.
    Takata Y; Tamura N; Fujita T
    J Immunol; 1984 May; 132(5):2531-7. PubMed ID: 6232320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complement enables the physiological elimination of immune complexes].
    Schifferli JA
    Ther Umsch; 1988 Feb; 45(2):74-8. PubMed ID: 3358245
    [No Abstract]   [Full Text] [Related]  

  • 7. Formation of soluble immune complexes by complement in sera of patients with various hypocomplementemic states. Difference between inhibition of immune precipitation and solubilization.
    Schifferli JA; Steiger G; Hauptmann G; Spaeth PJ; Sjöholm AG
    J Clin Invest; 1985 Dec; 76(6):2127-33. PubMed ID: 2934406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of rat complement by soluble and insoluble rat IgA immune complexes.
    Rits M; Hiemstra PS; Bazin H; Van Es LA; Vaerman JP; Daha MR
    Eur J Immunol; 1988 Dec; 18(12):1873-80. PubMed ID: 3220102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Solubilization and the behavior of solubilized IC in vivo].
    Ishida H; Koyama A; Narita M; Tojo S
    Nihon Jinzo Gakkai Shi; 1984 Jan; 26(1):21-9. PubMed ID: 6737781
    [No Abstract]   [Full Text] [Related]  

  • 10. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
    Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
    J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced complement-mediated immune complex solubilization in leprosy patients.
    Ramanathan VD; Sharma P; Ramu G; Sengupta U
    Clin Exp Immunol; 1985 Jun; 60(3):553-8. PubMed ID: 3874729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of glomerular immune complex deposits.
    McCluskey RT
    Lab Invest; 1983 Mar; 48(3):241-4. PubMed ID: 6219247
    [No Abstract]   [Full Text] [Related]  

  • 13. [A comparison between the quantitative fixation of the first four components of complement (C1, C4, C2 and C3) and of total complement during "in vitro" antigen-antibody reactions].
    Leroy C; Peltier AP
    Ann Immunol (Paris); 1973 Feb; 124(1):87-96. PubMed ID: 4723413
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritis.
    Naama JK; Mitchell WS; Whaley K
    Clin Exp Immunol; 1983 Nov; 54(2):429-38. PubMed ID: 6652966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo decomplementation of guinea pigs with cobra venom factor and anti-C3 serum: analysis of the requirement of C3 and C5 for the mediation of endotoxin-induced death.
    Drake WP; Pokorney DR; Kopyta LP; Mardiney MR
    Biomedicine; 1976 May; 25(3):91-4. PubMed ID: 949521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biological role of the complement system and the clinical importance of complement measurements.
    Füst G
    Haematologia (Budap); 1978-1979; 12(1-4):85-106. PubMed ID: 395046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of solubilization of immune aggregates by complement. Implications for immunopathology.
    Takahashi M; Czop J; Ferreira A; Nussenzweig V
    Transplant Rev; 1976; 32():121-39. PubMed ID: 790687
    [No Abstract]   [Full Text] [Related]  

  • 18. Physiological and pathological effects of activated complement.
    Dierich MP; Schulz T
    Haematologia (Budap); 1984; 17(1):3-16. PubMed ID: 6373514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance kinetics and organ uptake of complement-solubilized immune complexes in mice.
    Aguado MT; Mannik M
    Immunology; 1987 Feb; 60(2):255-60. PubMed ID: 3817872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the complement sequence by extracts of bacteria and fungi associated with hypersensitivity pneumonitis.
    Marx JJ; Flaherty DK
    J Allergy Clin Immunol; 1976 Apr; 57(4):328-34. PubMed ID: 1262608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.